¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"visual pathway"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • visual angle
    ½Ã°¢°¢
  • visual aphasia
    ½Ã°¢¾ð¾î»ó½ÇÁõ, ½Ã°¢½Ç¾îÁõ
  • visual area
    ½Ã°¢¿µ¿ª
  • visual association area
    ½Ã°¢¿¬ÇÕ¿µ¿ª
  • visual aura
    ½Ã°¢Á¶Áü
  • visual axis
    ½Ã¼±Ãà, ½ÃÃà
  • visual cell
    ½Ã°¢¼¼Æ÷
  • visual center
    ½Ã°¢ÁßÃß
  • visual cone
    ½Ã°¢¿ø»Ô
  • visual confusion
    ½Ã°¢È¥¶õ
  • visual cortex
    ½Ã°¢°ÑÁú, ½Ã(°¢)ÇÇÁú
  • visual defect
    ½Ã(°¢)°á¼Õ
  • visual deprivation
    ½Ã°¢¹ÚÅ»
  • visual discrimination
    ½Ã°¢½Äº°
  • visual disturbance
    ½Ã·ÂÀå¾Ö, ½Ã°¢Àå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • visual cone
    (¢¡ocular cone) ½Ã°¢¿ø»Ô
  • visual confusion
    ½Ã°¢È¥¶õ
  • visual cortex
    ½Ã°¢°ÑÁú, ½Ã°¢ÇÇÁú
  • visual acuity test chart
    ½Ã·Â°Ë»çÇ¥
  • visual defect
    ½Ã°¢°á¼Õ
  • visual deprivation
    ½Ã°¢Â÷´Ü
  • visual discrimination
    ½Ã°¢½Äº°
  • visual disturbance
    ½Ã·ÂÀå¾Ö, ½Ã°¢Àå¾Ö
  • visual field defect
    ½Ã¾ß°á¼Õ
  • visual efficiency
    ½Ã°¢È¿À²
  • visual field examination
    ½Ã¾ß°Ë»ç
  • kinetic visual field
    µ¿Àû½Ã¾ß
  • static visual field
    Á¤Àû½Ã¾ß
  • visual field
    ½Ã¾ß
  • visual hallucination
    ȯ½Ã, º¸ÀÓȯ°¢
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pain pathway
    Åë°¢Àü´Þ·Î(÷ÔÊÆîîÓ¹ÖØ).
  • pancreas,protein secertion pathway
    ´Ü¹éÁúºÐºñ°æ·Î(Ó±ÛÜòõÝÂÝôÌèÖØ)
  • parallel pathway
    (°¨°¢Á¤º¸Ã³¸®ÀÇ)ÆòÇà°æ·Î
  • pathway
    °æ·Î(ÌèÖØ).
  • pentose phosphate pathway
    ¿Àź´ç ÀλêÈ­ ¹ÝÀÀ
  • phosphogluconate oxidative pathway
    ±Û·çÄÜ»ê»êÈ­°æ·Î, ÀÎ´ç¿ø»êÈ­°æ·Î(ìÝÓØ ê«ß«ûùÌèÖØ).
  • proximal common pathway
    ±ÙÀ§°øÅë°æ·Î.
  • pyruvate pathway
    ÇÇ·çºê»ê¿°´ë»ç°æ·Î(¡­ß«ç¤ÓÛÞóÌèÖØ).
  • reflex path =r. pathway, r. tract
    ¹Ý»ç°æ·Î(ÚãÞÒÌèÖØ).
  • signaling pathway, interneuronal
    ½Å°æ¼¼Æ÷°£ ½ÅÈ£Àü´Þ°æ·Î
  • spinothalamic pathway
  • supranuclear pathway
    ÇÙ»ó·Î
  • transcellular pathway
    ü°­°æ·Î(ô÷Ë·ÌÓÖØ)
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • aphasia, visual
    ½Ã°¢¼º ½Ç¾îÁõ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hoxose phosphoketolase pathway
    Çí¼Ò½º Æ÷½ºÆ÷ŰÅç·¹À̽º °æ·Î(ÌèÖØ)
  • intrinsic pathway
    ³»ÀÎ °æ·Î(Ò®ì×ÌèÖØ)
  • -ketoadipate pathway
    -ÄÉÅ侯µðÇÁ»ê(ß«)°æ·Î(ÌèÖØ)
  • -ketoglutrate pathway
    -ÄÉÅ䱸¸£Å¸¸£»ê(ß«) °æ·Î(ÌèÖØ)
  • layered metabolic pathway
    Ãþ´ë»ç°æ·Î(öµÓÛÞóÌèÖØ)
  • linear metabolic pathway
    ¼±Çü ´ë»ç°æ·Î(àÊû¡ÓÛÞóÌèÖØ)
  • long patch pathway
    ÀåÆí °æ·Î(íþø¹ÌèÖØ)
  • mandelate pathway
    ¸¸µ¨»ê(ß«) °æ·Î(ÌèÖØ)
  • metabolic pathway
    ´ë»ç °æ·Î(ÓÛÞóÌèÖØ)
  • oxaloacetate pathway
    ¿Á»ì¾Æ¼¼Æ®»ê(ß«) °æ·Î(ÌèÖØ)
  • pathway
    °æ·Î(ÌèÖØ)
  • pentose phosphate pathway
    Àλê(×òß«ÆæÅ佺 °æ·Î(ÌèÖØ)
  • pentose phosphoketolase pathway
    ÆæÅ佺 Æ÷½ºÆ÷ÄÉÅç·¹À̽º °æ·Î(ÌèÖØ)
  • phosphogluconate oxidative pathway
    Æ÷½ºÆ÷±Û·çÄÜ»ê(ß«) »êÈ­°æ·Î(ß«ûùÌèÖØ)
  • phosphogluconate pathway
    Æ÷½ºÆ÷±Û·çÄÜ»ê °æ·Î(ÌèÖØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AERPAP antegrade effective refractory period accessory pathway
APH alcohol-positive history; alternative pathway hemolysis; aminoglycoside phosphotransferase; antepart...
ED early-decision [applicant]; early differentiation; ectodermal dysplasia; ectopic depolarization; eff...
EM early memory; ejection murmur; electromagnetic; electron micrograph; electron microscopy, electron m...
EMP electric membrane property; electromagnetic pulse; Embden-Meyerhof pathway; external membrane potent...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
APC alternative pathway of complement
FP fast pathway
GSP general secretory pathway
PP perforant pathway
SP slow pathway
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • descending pathway
    ÇÏÇà °æ·Î
  • dorsal column pathway
    ¹è ôÁÖ °æ·Î
    Ã˰¢ÀÇ A
  • efferent neural pathway
    ¿ø½É¼º ½Å°æ·Î
    ÁßÃ߽Űæ°è·ÎºÎÅÍ Àü´ÞµÇ¾î ³ª°¡´Â ½Å°æ ÀÓÆÞ½º.
  • humoral pathway
    ü¾× Åë·Î
  • intrinsic pathway
    ³»ºÎ °æ·Î, ³»Àμº °æ·Î
  • medial pathway
    ³»Ãø °æ·Î
  • meridian pathway
    °æ¶ô, °æ·Î
    µ¿¾ç ÀÇÇп¡¼­ ¹°¸® ¿ä¹ý, ƯÈ÷ ħ±¸ Ä¡·áÀÇ À̷Рü°è·Î¼­ Áß¿ä½ÃµÇ´Â °æÇ÷
  • metabolic pathway
    ´ë»ç °æ·Î
  • neural pathway
    ½Å°æ °æ·Î, ½Å°æ Åë·Î
    ÀÓÆÞ½º°¡ Àü´ÞµÇ´Â ½Å°æ ±¸Á¶¹°.
  • orbiting pathway
    ±Ëµµ
  • paleothalamic pathway
    °í½Ã»ó Àü´Þ·Î
  • paramedian pathway
    Á¤Áß¹æ °æ·Î
  • pathway
    °æ·Î, Àüµµ·Î
    Àüµµ·Î¶ó°í ÇÏ´Â °ÍÀº ³ú ¶Ç´Â ô¼ö¿¡ À־ÀÇ ÁßÃß¿Í ½Åü ¸»Ãʸ¦ ¿¬°áÇÏ´Â Åõ»ç ½Å°æ·Î¸¦ ¸»ÇÏ´Â °ÍÀ¸·Î Åõ»ç ½Å°æ·Î´Â ½Ä¹° ½Å°æ°è¿¡ ¼ÓÇÏ´Â °Í°ú µ¿¹° ½Å°æ°è¿¡ ¼ÓÇÏ´Â °ÍÀ¸·Î ´ëº°ÇÒ ¼ö ÀÖ´Ù. ±×ÀÇ ¾î´À °Í¿¡µµ »óÇ༺
  • pentose hosphate pathway

    pentose nucleic acid (ÆæÅ佺 ÇÙ»ê

  • salvage pathway
    ±¸Á¦ °æ·Î, ÀçÀÌ¿ë °æ·Î
    ±âÁ¸ ¹°ÁúÀ» »ç¿ëÇØ ÇÕ¼ºÇÏ´Â °æ·Î.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Embden-Meyerhof pathway The main pathway for anerobic degradation of carbohydrate. Starch or glycogen is hydrolysed to glucose 1 phosphate and then through a series of intermediates, yielding two ATP molecules per glucose and producing either pyruvate which feeds into the tricarboxylic acid cycle) or lactate.
(18 Nov 1997)
Entner-Douderoff pathway A degradative pathway for carbohydrates in certain microorganisms (e.g., Pseudomonas sp.) that lack hexokinase, phosphofructokinase, and glyceraldehyde-3-phosphate dehydrogenase.
(05 Mar 2000)
Entner-Doudoroff pathway <biochemistry> A pathway that converts glucose to pyruvate and glyceraldehyde-3 phosphate by producing 6-phosphogluconate and then dehydrating it.
(09 Oct 1997)
extrinsic pathway <haematology> Initiation of blood clotting as a result of factors released from damaged tissue, as opposed to contact with a foreign surface (the intrinsic pathway).
Tissue thromboplastin (Factor III) in conjunction with Factor VII proconvertin) will activate Factor X that, once activated, converts prothrombin to thrombin.
(27 Jun 1999)
4-aminobutyrate pathway The pathway that ultimately converts 4-aminobutyrate to succinate; succinate is then converted to alpha-ketoglutarate, via the tricarboxylic acid cycle, which is then acted upon by glutamate dehydrogenase; glutamate is then decarboxylated to reform 4-aminobutyrate; an important pathway for those cells which make this neuroactive molecule.
Synonym: GABA pathway.
(05 Mar 2000)
lysogenic pathway <virology> The method by which a virus becomes a dormant, passive part of its host bacterium's genome (a lysogenic virus), choosing to insert its DNA into the host's and postponing completion of its lytic cycle, at which time it destroys the host and spreads its progeny to infect other bacterial cells (enters the lytic pathway).
(09 Oct 1997)
lytic pathway The steps in the method that a virus takes to complete a lytic cycle, including the production and assembly of progeny viruses with host cell machinery and the destruction of the host cell by rupturing its plasma membrane (lysis), releasing the progeny viruses in the process.
(09 Oct 1997)
accessory visual apparatus The eyelids, with lashes and eyebrows, lacrimal apparatus, conjunctival sac, and extrinsic muscles of the eyeball.
Synonym: organa oculi accessoria, accessory organs, accessory visual apparatus, adnexa oculi, appendages of eye.
(05 Mar 2000)
Bender Visual Motor Gestalt test <psychology> A psychological test used by neurologists and clinical psychologists to measure a person's ability to visually copy a set of geometric designs.
It consists of nine geometric designs on cards. The subject is asked to redraw them from memory after each one is presented individually. It is useful for measuring visuospatial and visuomotor coordination to detect brain damage.
Synonym: Bender Visual Motor Gestalt test.
(14 Aug 2000)
Broca's visual plane A plane drawn through the visual axes of each eye.
(05 Mar 2000)
receptor, visual The layer of rods and cones, the visual cells, of the retina.
(12 Dec 1998)
pattern recognition, visual Visually perceived characters, shapes, displays, or designs.
(12 Dec 1998)
visual Pertaining to vision or sight.
Origin: L. Visualis, from videre = to see
(18 Nov 1997)
visual acuity <microscopy> The ability to detect fine details or small distances with the eye. Visual acuity can vary substantially depending on the definition used and method of measurement chosen. Under favourable conditions, the resolution of the human eye or ability to distinguish the twoness of adjoining lines, is about I minute of arc while the threshold delectability, or the detection of misaligned steps in a line (which is also a form of visual acuity), can be as low as a fraction of a second of arc.
(05 Aug 1998)
visual agnosia The inability to recognise objects by sight; usually caused by bilateral parieto-occipital lesions.
Synonym: optic agnosia.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á